Cookies help us to understand how you use our website so that we can provide you with the best experience when you are on our site. To find out more, read our privacy policy and cookie policy.
Manage Cookies
A cookie is information stored on your computer by a website you visit. Cookies often store your settings for a website, such as your preferred language or location. This allows the site to present you with information customized to fit your needs. As per the GDPR law, companies need to get your explicit approval to collect your data. Some of these cookies are ‘strictly necessary’ to provide the basic functions of the website and can not be turned off, while others if present, have the option of being turned off. Learn more about our Privacy and Cookie policies. These can be managed also from our cookie policy page.
Strictly necessary cookies(always on):
Necessary for enabling core functionality. The website cannot function properly without these cookies. This cannot be turned off. e.g. Sign in, Language
Analytics cookies:
Analytical cookies help us to analyse user behaviour, mainly to see if the users are able to find and act on things that they are looking for. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. Tools used: Google Analytics
Social media cookies:
We use social media cookies from Facebook, Twitter and Google to run Widgets, Embed Videos, Posts, Comments and to fetch profile information.
Patients’ experiences during treatment with Immunotherapy
Share Patients’ experiences during treatment with Immunotherapy on FacebookShare Patients’ experiences during treatment with Immunotherapy on TwitterShare Patients’ experiences during treatment with Immunotherapy on LinkedinEmail Patients’ experiences during treatment with Immunotherapy link
Immunotherapy is a cancer treatment that helps your immune system recognise and fight off cancer cells. Immune Checkpoint Inhibitors (ICIs) are a type of Immunotherapy that block proteins that stop the immune system from attacking cancer cells.
Immunotherapy can be used to treat many different types of cancer. This study is looking at patients with gastrointestinal cancer who are being treated with Immune Checkpoint Inhibitors. Gastrointestinal cancers include oesophagus, stomach, liver (HCC), small and large intestine, pancreas, biliary system, colon, rectum and anus cancer.
We would like to hear about your experience of this treatment, and if you developed any side effects. We will use this information to see if we can improve patient care and follow up.
If you are or have been treated with Immune Checkpoint Inhibitors for gastrointestinal cancer or any other type of cancer (or you are a carer of someone in this position) please:
Share your story below - tell us about your experience of treatment and the information and support received from healthcare professionals. You can also email this to [email protected]
Share your ideas below - where do you go for information, advice and support?
Be part of a patient advisory group to support the research and have input into the design of this project. This will be a virtual group that will meet at key points in the project. Email [email protected] to register your interest.
Immunotherapy is a cancer treatment that helps your immune system recognise and fight off cancer cells. Immune Checkpoint Inhibitors (ICIs) are a type of Immunotherapy that block proteins that stop the immune system from attacking cancer cells.
Immunotherapy can be used to treat many different types of cancer. This study is looking at patients with gastrointestinal cancer who are being treated with Immune Checkpoint Inhibitors. Gastrointestinal cancers include oesophagus, stomach, liver (HCC), small and large intestine, pancreas, biliary system, colon, rectum and anus cancer.
We would like to hear about your experience of this treatment, and if you developed any side effects. We will use this information to see if we can improve patient care and follow up.
If you are or have been treated with Immune Checkpoint Inhibitors for gastrointestinal cancer or any other type of cancer (or you are a carer of someone in this position) please:
Share your story below - tell us about your experience of treatment and the information and support received from healthcare professionals. You can also email this to [email protected]
Share your ideas below - where do you go for information, advice and support?
Be part of a patient advisory group to support the research and have input into the design of this project. This will be a virtual group that will meet at key points in the project. Email [email protected] to register your interest.
